Home

Syllabus

Lecture Slides

Problem Sets

Keys to Exams and Homework

Links

• Abbott Laboratories Discovering, developing and marketing innovative health care solutions across the spectrum of health care.
• Acrongenomics A research and development nanobiotechnology company developing nanomolecular diagnostics for the Life Sciences Industry.
• Acrongenomics Focusing on the development of a platform comprised of molecular human diagnostic tools for various diseases.
• Adolar Committed to the development of novel analgesics and pain-related therapeutics based upon recent advances in proprietary medicinal chemistry and recombinant opioid receptor technology.
• Allergan
• Allergy information Schering
• Alliance Pharmaceutical Focusing on the application of scientific discoveries that can be developed into innovative drug products.
• AlphaRx A pharmaceutical company specializing in the formulation of therapeutic products using proprietary drug delivery technologies; core competent is in the development of novel drug formulations for compounds that are otherwise insoluble or poorly soluble in water.
• ALZA Focussing on the development of drug delivery-based pharmaceuticals.
• Amaxa Biosystems A research-oriented, rapidly expanding biotech company focusing on the development of innovative gene transfer technologies.
• American Home Products Vaccines, prescription drugs, biotechnology, agricultural and animal healthcare products.
• Amgen
• Amgen Germany
• Amylin Pharmaceuticals Focused on developing novel medicines for treating metabolic disorders.
• Angiotech Pharmaceuticals Development of medical device coatings and treatments for chronic inflammatory diseases through reformulation of the anticancer drug, paclitaxel.
• Antigenics Developing personalized immunotherapeutics and treatments for cancers, infectious diseases and autoimmune disorders.
• Antisoma Aiming to develop tumour targeted products that provide safer and more effective methods of diagnosing and treating cancer.
• Applied Molecular Evolution Discovering, developing and commercializing optimized human biotherapeutics.
• Arcadia Biosciences Developing and commercializing biotechnologies that make agriculture more economically and environmentally sustainable.
• Ardais A clinical genomics company applying actual human disease as the discovery model in pharmaceutical research.
• Ariad Pharmaceuticals Discovery and development of proprietary platform technologies and small-molecule therapeutic products based on gene regulation and signal transduction.
• Astra Pharmaceuticals
• AstraZeneca Pharmaceutical company with business is focused on seven major therapeutic areas: cardiovascular, central nervous system, gastrointestinal, infection, oncology, pain control and anaesthesia, and respiratory.
• AVAX Technologies Oncology treatments.
• Aventis Biotechnological custom process development, custom manufacturing and product development. Pharma and agriculture.
• Avigen Development of gene therapy products derived from adeno-associated virus ("AAV") for the treatment of inherited and acquired diseases.
• Avonex Interferon beta-1a information.
   
• Baxter
• Bayer
• Berlex Betaseron® Multiple Sclerosis Resource Center
• Beyond Genomics Applying systems biology to drug discovery and development; proprietary BioSystematics and BioSystem marker technology.
• Bio Balance A Biotechnology/Pharmaceutical Discovery Company.
• Biogen Biotechnology company principally engaged in developing genetically engineered human pharmaceuticals.
• Biological Mimetics Scientific services including virology, gene expression, molecular biology, and immunology for academic, institutional, and pharmaceutical laboratories.
• BioPartners A biopharmaceutical company specialising in accelerating the global development and commercialisation of high quality recombinant biopharmaceutical products.
• Biopharmacopae Design International Identification and development of new molecules with drug-like properties from natural sources using a proprietary library and HTS adapted for natural extracts. Indications under development: new cancer approach and skin diseases.
• BioProtein Technologies Dedicated to the production of therapeutic proteins in the milk of transgenic rabbits.
• Biopure A privately held biopharmaceutical company that develops, manufactures and markets oxygen-carrying hemoglobin solutions, or "oxygen therapeutics," for use in veterinary and human medicine.
• biotica A pharmaceutical company focused on the discovery and development of novel anti-cancer drugs through synthetic biology of natural products known as polyketides.
• Biovail A full-service pharmaceutical company that applies its proprietary drug delivery technologies in developing "oral controlled-release" products.
• BioZak Discovering, developing and delivering innovative antiviral medicines to fight against life threatening diseases.
• Boehringer Ingelheim Partnerships for contract manufacturing of biopharmaceuticals in mammalian cell culture and microorganisms.
• Boehringer Mannheim As of March 1998, Roche Molecular Biochemicals.
• Bristol-Myers Squibb Medicines, nutritionals and medical devices, worldwide.
   
• Cangene Developing , manufacturing, and commercializing of specialty hyperimmune plasma and biotechnology products.
• Caprion Technology for the quantitative profiling of biological systems at the level of proteins.
• Cara Therapeutics An emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation.
• Cardiome Tissue targeted cardiac drugs.
• Cell Genesys Focused on the development and commercialization of gene therapies to treat cancer and other major, life-threatening diseases.
• Cell Therapeutics, Inc. Focussing on the discovery, development, and commercialization of small molecule drugs for the treatment of cancer and inflammatory and immune diseases.
• CEL-SCI Corporation Developments in natural immunotherapy.
• Ceregene Discovery and development of novel genetic therapeutics for the treatment of neurological disorders.
• Chiron Combining diagnostic, vaccine and therapeutic strategies against many diseases. cGMP contract manufacturing services for large-scale microbial fermentation, recovery and downstream purification.
• Chrysalon Specialising in pharmaceutical researchanddevelopment, and particularly in the design and optimisation of small organic molecules with therapeutic potential.
• Chugai Pharma Europe
• Chugai Pharmaceutical Co.
• Ciba See Novartis
• Ciba Specialty Chemicals Discovery, manufacture and marketing of innovative specialty chemicals.
• Cogent Neurosciences Focus is in the area of ischemic brain insult: stroke, traumatic brain injury and epilepsy.
• Corixa Ttreating and preventing autoimmune disease, cancer and infectious disease by understanding and directing the immune system.
• Cytos Pharmaceuticals Developing commercially important pharmaceutical products relating to the potential therapeutic use of the essential amino acid L-histidine.
   
• deCODE genetics Iceland
• Dermik Laboratories
• Destiny Pharmaceuticals Conducts proprietary and contract research within the pharmaceutical R&D business sector; identifies and develops patented therapeutic pharmaceutical technologies for exploitation by the pharmaceutical industry.
• diaDexus Discovery and validation of novel genomic biomarkers for the detection and treatment of disease.
• DNA Phenomics Engaged in the discovery and production of genomic-based personalized medical solutions.
• domantis A biotechnology company engaged in the discovery and development of a new generation of proprietary protein products that incorporate the biological benefits and commercial advantages of both large proteins and small molecules.
• Draxis Health Veterinary pharmaceuticals and DRAXIMAGE, engaged in the research, development, manufacture, marketing and sale of radiopharmaceuticals for diagnostic and therapeutic purposes.
• Durect Products to treat chronic debilitating disease, and technologies that enable biotechnology products.
• DyoDelta Biosciences Specializing in supporting biotech and pharma companies in corporate partnerships.
   
• Ecopia Biosciences New antibacterial, antifungal and anticancer agents.
• Eden Biodesign Design and development of biopharmaceutical medicines.
• elan Focused on the discovery, development and marketing of products in neurology, pain management and autoimmune diseases.
• Eli Lilly and Company
• Emergent BioSolutions A biologics company focused on the research, development and manufacture of novel vaccines and related products for prophylactic and therapeutic use against common diseases and biological weapons of mass destruction.
• Enzo Therapeutics Developing medicines based on genetic and immune regulation to combat infectious diseases, autoimmune-based diseases and cancers.
• Eskayef Pharmaceutical company in Bangladesh engaged in the manufacture and marketing of therapeutic drugs, bulk pellets and animal health and nutrition products.
• EURAND Specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products using our innovative drug delivery technologies.
• Euroscreen Drug discovery company focussed on "de-orphanizing" G protein-coupled receptors (GPCR's).
• ExonHit Therapeutics Develops, applies and markets specific qualitative gene profiling technology for diagnostic, predictive toxicology and therapeutic purposes.
   
• Fujisawa Healthcare USA
   
• Genelabs Engaged in the discovery and development of a new class of pharmaceutical products that selectively regulate gene expression and the development of GL701, a proprietary hormone treatment for systemic lupus erythematosus (SLE or lupus).
• Genentech
• Geneohm Uses the flow of electric current through DNA to detect genetic mutations.
• Genetronics Biomedical "A drug delivery company specializing in developing technology and hardware which potentially will allow physicians more efficiently and cost-effectively to deliver life-saving drugs or beneficial genes to patients with catastrophic illnesses, including cancer and heart disease."
• Gen-Probe Developing, manufacturing, and commercializing diagnostic products based on a patented DNA probe technology.
• Genzyme Specialized pharmaceutical intermediates and fine chemicals, custom development of small molecule pharmaceuticals.
• Gilead Sciences Focused on infectious diseases and oncology.
• GlaxoSmithKline
• GMP Genetics Genetics testing technologies.
• Graffinity Lead discovery and development of small molecule pharmaceuticals.
   
• Helicon Therapeutics Drug discovery for disorders of the memory.
• Helix BioPharma Focused on the discovery and development of innovative anti-cancer therapeutics.
• Hoechst Internet forum.
• Houghten Pharmaceuticals, Inc. Using combinatorial chemistry to pursue the discovery of novel, small molecule drug therapies.
• HUM-MOLGEN Registry of Biotechnology Companies
   
• Iconix Pharmaceuticals Chemogenomics platform includes an integrated database architecture to bridge genomics and drug design, novel bio- and chemoinformatics software, and advanced expression array and cellular assay development capabilities.
• ImClone Systems Development of novel treatments for cancer and cancer-related disorders.
• ImmunoGen Focused on Tumor-Activated Prodrugs for colorectal cancer, small-cell lung cancer and other aggressive malignancies.
• Immusol Applying a proprietary drug target discovery technology called Inverse Genomics® to identify therapeutic targets in biological systems.
• Impotence information Pharmacia & Upjohn
• Intronn Technology for gene therapy that exploits the differential gene expression between normal and diseased cells.
• Ixion Biotechnology Dedicated to discovering and developing breakthrough medical science to detect, diagnose, treat and/or prevent a group of diseases including diabetes, kidney stones and other oxalate related disorders.
   
• Johnson & Johnson
   
• Kosan Biosciences Proprietary technologies to develop drug candidates from an important class of natural product compounds known as polyketides, a source of many pharmaceuticals, including antibiotics, anticancer drugs, cholesterol-lowering drugs, immunosuppressants and other therapeutics.
   
• Labopharm Reformulating existing drugs to deliver with controlled-release technology.
• Laboratorios Syva Producing and marketing veterinary pharmaceuticals and biologicals since 1941.
• Lexrite Engineering antibody payload deliverysystems for targeted cancer therapeutics.
• Lifespan Developing heparin tests based on a novel new protein.
• Lundbeck Focusing solely on the treatment of diseases of the central nervous system.
   
• MacroGenics Develops, manufactures and commercializes biotechnology products including immunotherapeutics for cancer, infectious diseases, and autoimmune disorders.
• Magistral Biotech Research, development, manufacturing and marketing of natural health products whose therapeutic effects have been subject to scientifically review.
• MannKind A biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer.
• Maxim Pharmaceuticals A bio-pharmaceutical company with a diverse pipeline of therapeutic candidates for life-threatening cancers, hepatitis and other liver diseases.
• Medco Research
• Medeva Develops, manufactures and markets prescription pharmaceutical products. Focused principally on central nervous system; respiratory; vaccines; hospital products; gastrointestinal; and dermatology.
• Medicis Pharmaceutical Corp.
• MediGene Dedicated to the discovery, development and commercialization of novel molecular therapies for the treatment of major, life-threatening diseases.
• Memory Pharaceuticals Neuropharmaceutical development.
• Merck MSD ... Merck Sharp & Dohme
• Microbia Harnessing the regulatory circuitry that governs microbial physiology and metabolism to develop new anti-infective therapeutics.
• Micrologix Biotech Developing treatment options for life-threatening diseases caused by multidrug-resistant bacteria.
• Mikhaus Laboratories A clinical stage biopharmaceutical company focused on therapeutics for chronic diseases.
• Milagen Engaged in the discovery, validation and development of pharmaceutical products.
• Millenium Pharmaceuticals Product development using genomics methods.
• Mixture Sciences Specializes in biomedical research and drug discovery; uses a combination of proprietary and in-licensed technologies for the discovery of therapeutic and diagnostic candidates for the treatment of HIV/AIDS, cancer, diabetes, multiple sclerosis, and infectious diseases, including Lyme Disease.
• Molecular Nanosystems Research and development of nanotube-based products using site-selective chemical vapor deposition technology.
• MorphoSys Focussing on the development of fully human recombinant antibodies for use in therapeutic, diagnostic and research applications.
• Morphotek A biotechnology company focused on developing genetically diverse organisms for agricultural, life science, and pharmaceutical use.
• Myriad A biopharmaceutical company focused on the development of therapeutic and diagnostic products using genomic and proteomic technologies.
   
• NeoGenesis Chemical Genetics strategy that utilizes drug-like, small molecule ligands very early in the discovery process to empirically determine and prioritize the biological utility and drugability of poorly characterized, disease-associated proteins.
• NeoRx Cancer therapeutic development company with technologies for targeted delivery of therapeutic agents, including radiopharmaceuticals, directly to sites of disease.
• Neurochem Focused on the development of therapeutic treatments and diagnostic tools for central nervous system and amyloid related diseases.
• NeXstar Pharmaceuticals
• Novartis
• Novo Nordisk A/S Pharmaceutical and industrial enzyme products.
• NUCRYST Development through use of noble metal nanocrystalline pharmaceutical and medical device technologies.
• Nutra Pharma A biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases.
   
• OPTIME Therapeutics Develops non-viral vectors for gene therapy; based on liposomes, protein-nanospheres and kationic lipids develops novel, fourth-generation gene-vectors.
• Organon The largest Dutch research-based pharmaceutical company and the largest pharmaceutical business unit of Akzo Nobel.
• Otsuka Pharmaceutical Co.
   
• Pacific Edge Biotechnology Biomedical company developing novel diagnostic and therapeutic products to manage cancer and other diseases (new Zealand).
• Paradigm Genetics A biotechnology company applying its proprietary systems biology platform to the discovery of drugs and agrichemicals
• Pfizer Includes Agouron, Parke-Davis, Monsanto,Pharmacia Upjohn
• Phares Drug Delivery AG A drug delivery company specializing in the screening and formulation of poorly water soluble compounds to maximize bioavailability.
• PhRMA Pharmaceutical Research and Manufacture of America ... excellent source of information concerning pharmaceutical development.
• Proctor & Gamble Health Care
• Profos AG Resource for work-force solutions to the universities, government laboratories, biotechnology and pharmaceutical companies.
• Protherics Developing and licensing products for niche markets.
• Purdue Pharma Research, development, marketing, sales, distribution and licensing of prescription pharmaceuticals, over the counter medicines and hospital products.
   
• Receptor BioLogix Developing a new class of receptor modulator called Intron Fusion Proteins to treat cancer, autoimmune, metabolic and other diseases.
• Regeneron Pharmaceuticals Develops medicines for the treatment of serious medical conditions.
• Retroscreen Ltd. Screening for new antiviral drugs on behalf of customers, clinical trials, development of intellectual property, and joint research agreements.
• Roche
• Roxane Pain Institute
   
• Samaritan Pharmaceuticals Product-driven biopharmaceutical company dedicated to saving lives by incubating breakthrough discovery for Alzheimer's, cancer, high cholesterol, HIV and Parkinson's.
• Sandoz
• Sankyo Pharma U.S. subsidiary of Tokyo-based Sankyo
• SBC Schweitzer Biotech Provider of technologies to the aquatic and poultry vaccine industries; cooperates with academia, government institutions and industry to explore opportunities and develop patentable technologies.
• Sertanty A drug discovery technology company that uses advanced empirical data and computational techniques to discover novel small molecules that can be transformed into orally-available drugs.
• Shimoda Biotech Innovates therapeutic compounds in proprietary drug delivery systems, with cancer research as a primary focus.
• Sierra Sciences A biotechnology company seeking a medicine to prevent and/or reverse cellular senescence, an underlying cause of many diseases, particularly the diseases of aging.
• Signal Pharmaceuticals An integrated target and drug discovery company focused on identifying new classes of small molecule drugs that regulate genes and the production of disease-causing proteins.
• SLIL Biomedical Engaged in the discovery and development of a range of new cancer drugs, based on its world-leading position in the field of polyamine analogs and its proprietary Tumor Targeting and Delivery (TTD) technology.
• SmithKline Beecham
• Starpharma Drug development through dendrimer-based nanotechnology.
• Stryker Biotech Developing new products for bone repair based on the Bone Morphogenetic Protein, recombinant human Osteogenic Protein-1 (rhOP-1).
• SUGEN Developing new drugs to target signal transduction pathways inside the body's cells.
• Synthetic Genomes Developing scientific processes to enable industry to design and test desired genetic modifications
• Syrrx A drug discovery company based on rational drug design.
   
• Targeted Genetics Discovery and development of molecular medicines to prevent or treat acquired, inherited and infectious diseases that have significant unmet medical need.
• Tassa Pharmaceuticals Developing next generation anti-infective compounds for treatments for tenacious and drug resistant strains of bacteria.
• Tensor Biosciences Brain-on-a-Chip™ technology combines the automated real-time analysis of electrical activity in the brain with advanced pattern analysis and classification software. Tensor is using these tools to identify therapeutics for psychiatric and neurodegenerative disorders.
• Tularik Development of medicines that regulate gene expressions.
   
• U3 Pharma AG Biotherapeutic products to treat cancer and hyperproliferative diseases.
   
• Vertex Pharmaceutical Focused on the discovery, development and commercialization of breakthrough drugs for a range of serious diseases.
• Victhom Human Bionics Develops orthotics and prosthetics, neurotechnology with neurosensor and neurostimulator implants, and active biomaterials.
• VISCUM AG A biopharmaceutical company that develops drugs from various natural sources; focuses on rapid preclinical and clinical development as well as on registration and market launch of novel therapeutic agents mainly in the oncological field.
• Viventia Biotech Developing innovative therapeutics based upon the human immune response to cancer.
   
• Xoma Develops biopharmaceuticals targeting cancer, immunological disorders and infectious diseases.
   
• Zila Focused on oral care.
• ZymoGenetics Leverages its expertise in bioinformatics and biology to discover novel therapeutic proteins.